drugset / Trial / NCT00000234
Alternate Day Buprenorphine Administration, Phase XI - 16
CrossoverTreatment
Summary
The purpose of this study is to evaluate open buprenorphine dosing with dose choice after open exposure.
Timeline
- Start
- —
- Primary completion
- —
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Buprenorphine | Other / unclassified | — | — |